Latest News about EDIT
Recent news which mentions EDIT
Stocks That Hit 52-Week Highs On Monday
December 07, 2020
From Benzinga
Did Google's DeepMind Just Revolutionize Medicine?
December 05, 2020
From Motley Fool
10 Health Care Stocks With Unusual Options Alerts In Today's Session
December 01, 2020
From Benzinga
Is Gene Editing Already Leaving CRISPR Therapeutics Behind?
November 21, 2020
From Motley Fool
54 Biggest Movers From Yesterday
November 04, 2020
From Benzinga
12 Healthcare Stocks Moving In Tuesday's Intraday Session
November 03, 2020
From Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
November 03, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For November 3, 2020
November 03, 2020
From Benzinga
12 Healthcare Stocks Moving In Monday's After-Market Session
November 02, 2020
From Benzinga
Understanding Editas Medicine's Unusual Options Activity
November 02, 2020
Tickers
EDIT
From Benzinga
Understanding Editas Medicine's Unusual Options Activity
October 21, 2020
Tickers
EDIT
From Benzinga
Better Buy: CRISPR Therapeutics vs. Editas Medicine
September 30, 2020
From Motley Fool
Editas Medicine, Inc. (EDIT) Q2 2020 Earnings Call Transcript
August 07, 2020
Tickers
EDIT
From Motley Fool
From Benzinga
110 Biggest Movers From Yesterday
August 07, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
August 06, 2020
From Benzinga
From Motley Fool
95 Stocks Moving In Thursday's Mid-Day Session
August 06, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
August 06, 2020
From Benzinga
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
August 02, 2020
From Benzinga
If You Invested $100 in CRISPR Therapeutics' IPO, This Is How Much Money You'd Have Now
July 26, 2020
From Motley Fool
Could Editas Medicine Be a Millionaire-Maker Stock?
July 25, 2020
From Motley Fool
Is CRISPR Therapeutics Stock a Buy?
July 25, 2020
From Motley Fool
2 Best Gene-Editing Stocks to Buy in July
July 21, 2020
From Motley Fool
Where Will CRISPR Therapeutics Be in 5 Years?
July 17, 2020
From Motley Fool
3 Top Biotech Stocks to Watch in July
July 09, 2020
From Motley Fool
Better Buy: Editas Medicine vs. Intellia
July 02, 2020
From Motley Fool
From MarketWatch
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.